VVOS
Vivos Therapeutics, Inc.Healthcare · $2M market cap
Verdict
We can't put a fair value on VVOS right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow VVOS
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 14, 2026: no open-market purchases and 2 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
Questions about VVOS
Are insiders buying VVOS?
Since Sep 14, 2026: no open-market purchases and 2 other filings (stock awards, tax withholding and similar).
How can I check VVOS's value myself?
Use the free Sticker Price calculator, already filled with VVOS's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Medical - Devices
About Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 26, 2026. How the Payback Price works